Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) SHH

Currency In CNY

AD

Valuation

Market Cap70.1B
Enterprise Value97.44B
P/E Ratio17.23
PEG Ratio2.37
Price/Sales Ratio1.43
Price/Book Ratio1.2
Enterprise/Revenue2.09
Enterprise/EBITDA16.15

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.08
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue41.5B
Revenue/Share16.19
Gross Profit19.12B
EBITDA9.99B
Net Income3.37B
Diluted EPS1.27

Balance Sheet

Total Cash15.76B
Total Cash/Share5.97
Total Debt41.48B
Total Debt/Equity0.82
Current Ratio0.98
Book Value Per Share25.04

Price History

52-Week Change-19.92
52-Week High29.13
52-Week Low20.85
Moving Average 50 Days22.99
Moving Average 200 Days24.11

Statistics

Average Volume22.14M
Shares Outstanding2.67B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.39
Trailing Annual Dividend Yield1.7
Payout Ratio0.31
Last Split Factor3:2
Last Split DateJuly 26, 2010
AD